Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019

Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019 Publisher

Safiri S^{1, 2} ; Nejadghaderi SA^{3, 4} ; Karamzad N⁵ ; Kaufman JS⁶ ; Carsonchahhoud K^{7, 8} ; Bragazzi NL⁹ ; Sullman MJM^{10, 11} ; Beyranvand MR⁴ ; Mansournia MA¹² ; Almasihashiani A¹³ ; Collins GS^{14, 15} ; Kolahi AA⁴

Source: Frontiers in Endocrinology Published:2022

Abstract

Background: To report the burden of cancers attributable to high fasting plasma glucose (HFPG) by sex, age, location, cancer type and Socio-demographic Index (SDI) over the period 1990 to 2019 for 204 countries and territories. Methods: Using the Comparative Risk Assessment approach of Global Burden of Disease (GBD) study 2019, the burden of cancers attributable to HFPG was reported in 1990 and 2019. Results: Globally, in 2019 there were an estimated 419.3 thousand cancer deaths (95% UI: 115.7 to 848.5) and 8.6 million cancer DALYs (2.4 to 17.6) attributable to HFPG. By sex, 4.6 (1.1 to 9.9) and 4.0 (1.1 to 8.4) million global cancer DALYs were attributable to HFPG in men and women, respectively. The global age-standardized death and DALY rates of cancers attributable to HFPG (per 100,000) have increased by 27.8% (20.5 to 38.7%) and 24.5% (16.4 to 35.6%), respectively, since 1990. High-income North America (9.5 [2.7 to 18.8]) and Eastern Sub-Saharan Africa (2.0 [0.5 to 4.2]) had the highest and lowest regional age-standardized death rates, respectively, for cancers attributable to HFPG. In 2019, the global number of attributable cancer DALYs were highest in 65-69 age group. Moreover, there was an overall positive association between SDI and the regional age-standardized DALY rate for HFPG-attributable cancers. Conclusions: HFPG was associated with more burden in 2019. Preventive programs for diabetes and screening of individuals with diabetes for cancers, especially in older males living in developed countries, are required to arrest the large increases in HFPG-attributable cancers. Copyright © 2022 Safiri, Nejadghaderi, Karamzad, Kaufman, Carson-Chahhoud, Bragazzi, Sullman, Beyranvand, Mansournia, Almasi-Hashiani, Collins and Kolahi.

Related Docs

View other Related Docs

1. Burden of Cancers Attributable to High Fasting Plasma Glucose in the Middle East and North Africa Region, 1990–2019, Cancer Medicine (2023)

2. Impact of Diabetes Mellitus on Epithelial Ovarian Cancer Survival, BMC Cancer (2018)

3. National and Subnational Burden of Female and Male Breast Cancer and Risk Factors in Iran From 1990 to 2019: Results From the Global Burden of Disease Study 2019, Breast Cancer Research (2023)

Experts (# of related papers)

View all Related Experts

Mohammad Ali Mansournia (5)

Reza Shirkoohi (4)

Style	Citing Format
MLA	Safiri S, et al.. "Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019." Frontiers in Endocrinology, vol. 13, no. , 2022, pp. -.
APA	Safiri S, Nejadghaderi SA, Karamzad N, Kaufman JS, Carsonchahhoud K, Bragazzi NL, Sullman MJM, Beyranvand MR, Mansournia MA, Almasihashiani A, Collins GS, Kolahi AA (2022). Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019. Frontiers in Endocrinology, 13(), -.
Chicago	Safiri S, Nejadghaderi SA, Karamzad N, Kaufman JS, Carsonchahhoud K, Bragazzi NL, Sullman MJM, et al.. "Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019." Frontiers in Endocrinology 13, no. (2022): -.
Harvard	Safiri S et al. (2022) 'Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019', Frontiers in Endocrinology, 13(), pp. -.
Vancouver	Safiri S, Nejadghaderi SA, Karamzad N, Kaufman JS, Carsonchahhoud K, Bragazzi NL, et al.. Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019. Frontiers in Endocrinology. 2022;13():-.
BibTex	@article{ author = {Safiri S and Nejadghaderi SA and Karamzad N and Kaufman JS and Carsonchahhoud K and Bragazzi NL and Sullman MJM and Beyranvand MR and Mansournia MA and Almasihashiani A and Collins GS and Kolahi AA}, title = {Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019}, journal = {Frontiers in Endocrinology}, volume = {13}, number = {}, pages = {-}, year = {2022} }
RIS	TY - JOUR AU - Safiri S AU - Nejadghaderi SA AU - Karamzad N AU - Kaufman JS AU - Carsonchahhoud K AU - Bragazzi NL AU - Sullman MJM AU - Beyranvand MR AU - Mansournia MA AU - Almasihashiani A AU - Collins GS AU - Kolahi AA TI - Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019 JO - Frontiers in Endocrinology VL - 13 IS - SP - EP - PY - 2022 ER -

Science Communicator Platform

Authors

Abstract